4D Molecular Therapeutics, Inc. 8-K

Accession 0001193125-22-048643

Filing information

CIK: 0001650648
Report date: 2022-02-17
Filing date: 2022-02-22
Form: 8-K
Primary document: d323690d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.